A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
AI-Driven Drug Discovery & Computational Biology
What’s emerging Why it’s promising IP significance
-
First-Gen CRISPR (Cas9): Why Differentiation Was Limited
Core mechanism Therapeutic limitations Clinical realityCas9 works well as a research tool and for some ex vivo therapies, but the DSB mechanism imposes a ceiling on therapeutic scope. IP implicationEarly Cas9 patents emphasized: Differentiation was…
-
RNA-Based Therapeutics & Regulation
What’s emerging Why it’s promising IP significance
BioTech IP Review 